FDA Import Refusal 799-0975462-2/11/6 — AstraZeneca Canada Inc.
The FDA refused shipment 799-0975462-2/11/6 from AstraZeneca Canada Inc. (Canada) on May 28, 2019. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 28, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75